Behçet's disease: An update on pathogenesis, diagnosis and management of vascular involvement

Rheumatology Reports

Volumn 2, Issue 1, 2010, Pages 13-25

  Kaklamanis, Phaedon G ^a   Calamia, Kenneth T ^b  

^a ATHENS MEDICAL CENTER   (Greece)

^b MAYO CLINIC   (United States)

Author keywords

Arterial aneurysm; Beh et's disease; Corticosteroids; Endothelial dysfunction; Immunosuppressive agents; Vasculitis; Venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ATORVASTATIN; AZATHIOPRINE; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5 LEIDEN; CD3 ANTIGEN; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FIBRINOLYTIC AGENT; GAMMA INTERFERON; HOMOCYSTEINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; TETRACYCLINE; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANTIGEN PRESENTING CELL; BEHCET DISEASE; BRAIN ARTERY ANEURYSM; BRAIN VASCULITIS; BUDD CHIARI SYNDROME; CARDITIS; CAROTID ARTERY STENTING; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ANEURYSM; CORONARY STENT; DECOMPRESSION; DEEP VEIN THROMBOSIS; DIASTOLIC DYSFUNCTION; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG SAFETY; ENDOCARDIAL HEMORRHAGE; ENDOCARDIUM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; HEART ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNOPATHOGENESIS; INFERIOR CAVA VEIN THROMBOSIS; INTRACARDIAC THROMBOSIS; LARGE VESSEL VASCULITIS; LUNG EMBOLISM; MITRAL VALVE REGURGITATION; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERICARDITIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHLEBOGRAPHY; PLEURA EFFUSION; PLEURODESIS; PORTAL VEIN THROMBOSIS; PREVALENCE; PULMONARY ARTERY ANEURYSM; REVIEW; SEX DIFFERENCE; SMALL VESSEL VASCULITIS; SUPERFICIAL THROMBOPHLEBITIS; SUPERIOR VENA CAVA THROMBOSIS; SURGICAL DRAINAGE; SYMPTOMATOLOGY; T LYMPHOCYTE; TH1 CELL; THROMBOSIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VASCULITIS; VEIN THROMBOSIS;

EID: 77953468226     PISSN: 20367511     EISSN: 2036752X     Source Type: Journal    
DOI: 10.4081/rr.2010.e2     Document Type: Review

References (186)

1. Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behçet's Disease. Semin Arthritis Rheum 1998;27:197-217.
2. Gul A. Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001;19:S6-12.
3. Direskeneli H. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 2001;60:996-1002.
4. Gul A. Behcet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005;4:81-3.
5. Yazici H, Fresko I. Behcet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol 2005;23:S1-2.
6. Zouboulis CC. Epidemiology of Adamantiades-Behcet's disease. In: Zierhut M, Ohno S, eds. Immunology of Behcet's Disease. Amsterdam: Grafisch Produktiebedrijf Gorter 2003:1-16.
7. Zouboulis CC, Kotter I, Diawari D, et al. Adamantiades-Behçet's disease: epidemiology in Germany and in Europe. In: Lee S, Bang D, Lee E-S, Lee S, eds. In Behçet's disease A guide to its clinical understanding Textbook and Atlas Springer 2001:157-69.
8. Koç Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, et al. Vascular involvement in Behçet's disease. J Rheumatol 1992;19:402-10.
9. Schirmer M, Calamia KT. Is there a place for large vessel disease in the diagnostic criteria for Behçet's disease. J Rheumatol 1999;26:2511-2.
10. Wechsler B, Le Thi Huong D, Mouthon J-M, et al. Aspects capillaroscopiques peri - ungueaux au cours de la maladie de Behçet. A propos de 30 observations. Ann Dermatol Venereol 1984;111:543-50.
11. Pasqui AL, Pastorelli M, Puccetti L, et al. Microvascular assessment in Behcet disease: videocapillaroscopic study. Int J Tissue React 2003;25:105-15.
12. Ergun T, Gurbuz O, Harvell J, et al. The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behcet's disease. Int J Dermatol 1998;37:929-33.
13. Bang D, Honma T, Saito T, et al. Ultrastructure of vascular changes in cutaneous manifestations of Behcet's disease. Acta Derm Venereol 1988;68:33-40.
14. Balabanova M, Calamia KT, Perniciaro C, O'Duffy JD. A study of the cutaneous manifestations of Behçet's disease in patients from the United States. J Am Acad Dermatol 1999;41:540-5.
15. Chen KR, Kawahara Y, Miyakawa S, Nishikawa T. Cutaneous vasculitis in Behcet's disease: a clinical and histopathologic study of 20 patients. J Am Acad Dermatol 1997;36:689-96.
16. Jorizzo JL, Abernethy JL, White WL, et al. Mucocutaneous criteria for the diagnosis of Behcet's disease: An analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol 1995;32:968-76.
17. Mangelsdorf HC, White WL, Jorizzo JL. Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement. J Am Acad Dermatol 1996;34:745-50.
18. Kim B, LeBoit PE. Histopathologic features of erythema nodosum--like lesions in Behçet disease: a comparison with erythema nodosum focusing on the role of vasculitis. Am J Dermatopathol 2000;22:379-90.
19. Demirkesen C, Tuzuner N, Mat C, Senocak M, Buyukbabani N, Tuzun Y, et al. Clinicopathologic evaluation of nodular cutaneous lesions of Behçet syndrome. Am J Clin Pathol 2001;116:341-6.
20. Chun SI, Su WP, Lee S, Rogers RS III. Erythema nodosum-like lesions in Behçet's syndrome: a histopathologic study of 30 cases. J Cutan Pathol 1989;16:259-65.
21. Cevik C, Otahbachi M, Nugent K, Jenkins LA. Coronary artery aneurysms in Behçet's disease. Cardiovasc Revasculariz Med 2009;10:128-9.
22. Gul A, Esin S, Dilsen N, Konice M, Wigzell H, Biberfeld P. Immunohistology of skin pathergy reaction in Behcet's disease. B J derm 1995;132:901-7.
23. Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, et al. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995;38:426-33.
24. Zierhut M, Mizuki N, Ohno S, Inoko H, Gul A, Onoe K, et al. Immunology and functional genomics of Behcet's disease. Cell Mol Life Sci 2003;60:1903-22.
25. Pay S, Simsek I, Erdem H, Dinc A. Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 2007;27:417-24.
26. Ahn JK, Chung H, Lee DS, Yu YS, Yu HG. CD8brightCD56 T cells are cytotoxic effectors in patients with active Behcet's uveitis. J Immunol 2005;175:6133-42.
27. Kahan A, Hamzaoui K, Ayed K. Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal anti-bodies. J Rheumatol 1992;19:742-6.
28. Yamashita N, Kaneoka H, Kaneko S, Tet al. Role of gammadelta T lymphocytes in the development of Behçet's disease. Clin Exp Immunol 1997;107:241-7.
29. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 1999;42:1967-74.
30. Triolo G, Accardo-Palumbo A, Dieli F, et al. Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behcet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease. Arthritis Res Ther 2003;5:R262-8.
31. Kibaroglu A, Eksioglu-Demiralp E, Akoglu T, Direskeneli H. T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behcet's disease. Clin Exp Rheumatol 2004;22:S59-63.
32. Raziuddin S, al-Dalaan A, Bahabri S, Siraj AK, al-Sedairy S. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 1998;25:329-33.
33. Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet's disease. Arthritis Rheum 2004;50:2291-5.
34. Adamantiades B. A case of recurrent hypopyon iritis. Med Society of Athens 1930:586-93.
35. Duzgun N, Ates A, Aydintug OT, et al. Characteristics of vascular involvement in Behcet's disease. Scand J Rheumatol 2006;35:65-8.
36. Tunc R, Keyman E, Melikoglu M, et al. Target organ associations in Turkish patients with Behcet's disease: a cross sectional study by exploratory factor analysis. J Rheumatol 2002;29:2393-6.
37. Gharibdoost F, Davatchi F, Shahram F, et al. Clinical manifestations of Behçet's disease in Iran analysis of 2176 cases. In: Godeau P, Wechsler B, eds. Behçet's Disease. Paris: Elsevier Science Publishers, 1993:153-8.
38. Zouboulis CC. Extended venous thrombosis in Adamantiades-Behcet's disease. Eur J Dermatol 2004;14:268-71.
39. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease. Int J Dermatol 2003;42:346-51.
40. B'chir Hamzaoui S, Harmel A, Bouslama K, et al. La maladie de Behçet en Tunisie. Etude clinique de 519 cas. Revue Med Int 2006;27:742-50.
41. Houman MH, Ben Ghorbel I, Khiari Ben Salah I, et al. Deep vein thrombosis in Behcet's disease. Clin Exp Rheumatol 2001;19:S48-50.
42. Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003;82:60-76.
43. Naffati H, Ben Ghorbel I, Khanfir M, et al. Characteristics of deep venous thrombosis in Tunician Behçet's disease patients. 12th International conference on Behçet's disease. Clin Exp Rheumatol 2006;24:S-14, C21.
44. Zouboulis CC, Kotter I, Djawari D, et al. Current epidemiological data from the German Registry of Adamantiades-Behçet's disease. Adv Exp Med Biol 2003;528:43-8.
45. Tohme A, Aoun N, El-Rassi B, Ghayad E. Vascular manifestations of Behcet's disease. Eighteen cases among 140 patients. Joint Bone Spine 2003;70:384-9.
46. Calamia KT, Cohen MD, O'Duffy JD. Large vessel involvement in Behçet's disease (A). Proceedings of the Eighth International Congress on Behçet's disease, Reggio-Emilia, Italy. 1998:70.
47. Bayraktar Y, Balkanci F, Bayraktar M, M C. Budd - Chiari syndrome: a common complication of Behçet's disease. Am J Gastroenteral 1997;92:858-62.
48. Toumi S, Braham A, Gnaya H, Mhiri H, Ben Fredj F, Mrad B. Acute Budd - Chiari syndrome: a rare complication of Behçet's disease. 12th International Conference on Behçet's disease 2006; Lisbon: Clin Exp Rheumatol 2006. p. S-22, C9.
49. Korkmaz C, Kasifoglu T, Kebapci M. Budd-Chiari syndrome in the course of Behcet's disease: clinical and laboratory analysis of four cases. Joint Bone Spine 2007;74:245-8.
50. Benamour S, Zerhouni N, Alaoui F, et al. Vena cava thrombosis: 50 cases in a series of 1034 cases of Behçet's disease. 12th International Conference on Behçet's disease 2006; Lisbon: Clin Exp Rheumatol 2006. p. S-21, C1.
51. Bismuth E, Hadengue A, Hammel P, Benhamou JP. Hepatic vein thrombosis in Behçet's disease. Hepatology 1990;11:969-74.
52. Orloff LA, Orloff MJ. Budd-Chiari syndrome caused by Behcet's disease: treatment by side-to-side portacaval shunt. J Am Coll Surg 1999;188:396-407.
53. Han SW, Kim GW, Lee J, et al. Successful treatment with stent angioplasty for Budd-Chiari syndrome in Behcet's disease. Rheumatol Int 2005;25:234-7.
54. Seyahi E, Hamuryudan V, Hatemi G, et al. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome. Rheumatology 2007;46:1213-4.
55. Castelli P, Caronno R, Piffaretti G, Tozzi M, Lomazzi C, Lagana D, et al. Endovascular treatment for superior vena cava obstruction in Behcet disease. J Vasc Surg 2005;41:548-51.
56. Saidane L, Cherif E, Ben Hassine L, et al. Venous thrombosis in Behçet's disease. A retrospective study of 83 patients. 12th International Conference on Behçet's disease 2006; Lisbon: Clin Exp Rheumatol 2006. p. S-24, C-17.
57. Coplu L, Emri S, Selcuk ZT, et al. Life threatening chylous pleural and pericardial effusion in a patient with Behcet's syndrome. Thorax 1992;47:64-5.
58. Balbir-Gurman A, Guralnick L, Best LA, Nahir AM. Superior vena cava thrombosis and chylothorax in a young patient. Clin Exp Rheumatol 2005;23:S106.
59. Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 1999;122:2171-82.
60. Wechsler B, Vidailhet M, Piette JC, et al. Cerebral venous thrombosis in Behçet's disease: Clinical study and long-term follow-up of 25 cases. Neurology 1992;42:614-8.
61. Tunc R, Saip S, Siva A, Yazici H. Cerebral venous thrombosis is associated with major vessel disease in Behcet's syndrome. Ann Rheum Dis 2004;63:1693-4.
62. Siva A, Kantarci OH, Saip S, et al. Behçet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001;248:95-103.
63. Amoura Z, Dode C, Hue S, et al. Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behcet's disease. Arthritis Rheum 2005;52:608-11.
64. Wechsler B, Genereau T, Biousse V, et al. Pregnancy complicated by cerebral venous thrombosis in Behcet's disease. Am J Obstet Gynecol 1995;173:1627-9.
65. Saadoun D, Wechsler B, Resche-Rigon M, Trad S, Le Thi Huong D, Sbai A, et al. Cerebral venous thrombosis in Behcet's disease. Arthritis Rheum 2009;61:518-26.
66. Alan S, Ulgen MS, Akdeniz S, et al. Intima-media thickness and arterial distensibility in Behcet's disease. Angiology 2004;55:413-9.
67. Protogerou A, Lekakis J, Stamatelopoulos K, et al. Arterial wall characteristics in patients with Adamantiades-Behcet's disease. Adv Exp Med Biol 2003;528:399-404.
68. Ikonomidis I, Lekakis J, Stamatelopoulos K, et al. Aortic elastic properties and left ventricular diastolic function in patients with Adamantiades-Behcet's disease. J Am Coll Cardiol 2004;43:1075-81.
69. Chang HK, Kim SK, Lee SS, Rhee MY. Arterial stiffness in Behcet's disease: increased regional pulse wave velocity values. Ann Rheum Dis 2006;65:415-6.
70. Booth AD, Wallace S, McEniery CM, et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004;50:581-8.
71. Keser G, Aksu K, Tamsel S, et al. Increased thickness of the carotid artery intima-media assessed by ultrasonography in Behcet's disease. Clin Exp Rheumatol 2005;23:S71-6.
72. Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol 2001;37:517-20.
73. Kayikcioglu M, Aksu K, Hasdemir C, Keser G, Turgan N, Kultursay H, et al. Endothelial functions in Behcet's disease. Rheumatol Int 2006;26:304-8.
74. Ozdemir R, Barutcu I, Sezgin AT, Acikgoz N, Ermis N, Esen AM, et al. Vascular endothelial function and plasma homocysteine levels in Behcet's disease. Am J Cardiol 2004;94:522-5.
75. Cekmen M, Evereklioglu C, Er H, et al. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behcet's syndrome. Int J Dermatol 2003;42:870-5.
76. Shaker O, Ay El-Deen MA, El Hadidi H, et al. The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behcet disease. Br J Dermatol 2007;156:32-7.
77. Er H, Evereklioglu C, Cumurcu T, et al. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet's disease. Br J Ophthalmol 2002;86:653-7.
78. Salvarani C, Boiardi L, Casali B, et al. Vascular endothelial growth factor gene polymorphisms in Behcet's disease. J Rheumatol 2004;31:1785-9.
79. Bozoglu E, Dinc A, Erdem H, et al. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behcet's patients with venous thrombosis. Clin Exp Rheumatol 2005;23:S42-8.
80. Sahin M, Arslan C, Naziroglu M, et al. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dys-function in Behcet's disease. Ann Clin Lab Sci 2006;36:449-54.
81. Kim JU, Chang HK, Lee SS, et al. Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease and rheumatic diseases with vasculitis. Ann Rheum Dis 2003;62:1083-7.
82. Probst K, Fijnheer R, Rothova A. Endothelial cell activation and hypercoagulability in ocular Behcet's disease. Am J Ophthalmol 2004;137:850-7.
83. Aydintug AO, Tokgoz G, D'Cruz DP, Gurler A, Cervera R, Duzgun N, et al. Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol 1993;67:157-62.
84. Cervera R, Navarro M, Lopez-Soto A, et al. Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity. Ann Rheum Dis 1994;53:265-7.
85. Lee KH, Bang D, Choi ES, et al. Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behcet's disease. Arch Dermatol Res 1999;291:374-81.
86. Triolo G, Accardo-Palumbo A, Triolo G, et al. Enhancement of endothelial cell E-selectin expression by sera from patients with active Behcet's disease: moderate correlation with anti-endothelial cell anti-bodies and serum myeloperoxidase levels. Clin Immunol (Orlando). Fla. 1999;91:330-7.
87. Direskeneli H, Keser G, D'Cruz D, et al. Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behcet's disease. Clin Rheumatol 1995;14:55-61.
88. Dinc A, Takafuta T, Jiang D, et al. Anti-endothelial cell antibodies in Behcet's disease. Clin Exp Rheumatol. 2003;21:S27-30.
89. Zouboulis CC, Katsantonis J, Ketteler R, et al. Adamantiades-Behcet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 2000;292:279-84.
90. Ricart JM, Vaya A, Santaolaria M, et al. Dyslipidaemia in Behcet's disease as a thrombotic risk factor. Ann Rheum Dis 2006;65:1248-9.
91. Leiba M, Seligsohn U, Sidi Y, Harats D, Sela BA, Griffin JH, et al. Thrombophilic factors are not the leading cause of thrombosis in Behcet's disease. Ann Rheum Dis 2004;63:1445-9.
92. Altinbas A, Aytemur K, Tokgozoglu L, et al. Hyperhomocysteinaemia and activated protein C resistance in Behcet's disease. J Intern Med 2000;248:267-8.
93. Aksu K, Turgan N, Oksel F, et al. Hyperhomocysteinaemia in Behcet's disease. Rheumatology (Oxford). 2001;40:687-90.
94. Mungan AG, Can M, Acikgoz S, et al. Lipid peroxidation and homocysteine levels in Behcet's disease. Clin Chem Lab Med 2006;44:1115-8.
95. Harman M, Sayarlioglu M, Arslan H, et al. Fibrosing mediastinitis and thrombosis of superior vena cava associated with Behcet's disease. Eur J Radiol 2003;48:209-12.
96. Ozkan Y, Yardim-Akaydin S, Sepici A, et al. Assessment of homocysteine, neopterin and nitric oxide levels in Behcet's disease. Clin Chem Lab Med 2007;45:73-7.
97. Korkmaz C, Bozan B, Kosar M, et al. Is there an association of plasma homocysteine levels with vascular involvement in patients with Behcet's syndrome? Clin Exp Rheumatol 2002;20:S30-4.
98. Ricart JM, Vaya A, Todoli J, et al. Thrombophilic risk factors and homocysteine levels in Behcet's disease in eastern Spain and their association with thrombotic events. Thromb Haemost 2006;95:618-24.
99. Hamza M, Meyer O. Anticardiolipin anti-bodies in Behcet's disease. Presse Med 1986;15:1281.
100. Karmochkine M, Boffa MC, Wechsler B, et al. Absence of antiphospholipid antibodies in Behcet's disease. Ann Rheum Dis 1993;52:623.
101. Bang D, Ji HG, Choi YS, Lee S. Absence of lupus anticoagulants in Behcet's disease. Yonsei Med J 1991;32:326-9.
102. Efthimiou J, Harris EN, Hughes GR. Negative anticardiolipin antibodies and vascular complications in Behcet's syndrome. Ann Rheum Dis 1985;44:725-6.
103. Mader R, Ziv M, Adawi M, et al. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behcet's disease. J Rheumatol 1999;26:2404-8.
104. Nakano H, Oka H, Matsuda T, et al. Spontaneous platelet aggregation in patients with Behcet's disease by using laser-light scattering aggregometer. Adv Exp Med Biol 2003;528:437-41.
105. Yazici H, Hekim N, Ozbakir F, et al. Von Willebrand factor in Behcet's syndrome. J Rheumatol 1987;14:305-6.
106. Beyan E, Sadikoglu B, Ertugrul E, Beyan C. Von Willebrand factor antigen levels in Behcet disease. Am J Hematol 2005;79:70-2.
107. Ihle J, Kummerle-Deschner J, Orlikowsky T, et al. Factor V Leiden and venous thrombosis in a 4-yr-old girl with Behcet's syndrome. Rheumatology (Oxford). 2000;39:209-10.
108. Toydemir PB, Elhan AH, Tukun A, et al. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behcet's disease. J Rheumatol 2000;27:2849-54.
109. Verity DH, Vaughan RW, Madanat W, et al. Factor V Leiden mutation is associated with ocular involvement in Behcet disease. Am J Ophthalmol 1999;128:352-6.
110. Lespirit P, Wechsler B, Piette JC, et al. Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's disease. Ann Rheum Dis 1995; 54:860.
111. Silingardi M, Salvarani C, Boiardi L, et al. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis. Arthritis Rheum 2004;51:177-83.
112. Chen Y, Stanford MR, Wallace GR, et al. Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behcet's disease. Br J Ophthalmol 2003;87:1048-9.
113. Batioglu F, Atmaca LS, Karabulut HG, et al. Factor V Leiden and prothrombin gene G20210A mutations in ocular Behcet disease. Acta Ophthalmol Scand 2003;81:283-5.
114. Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Behcet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003;21:S35-7.
115. Haznedaroglu E, Karaaslan Y, Buyukasik Y, et al. Selectin adhesion molecules in Behcet's disease. Ann Rheum Dis 2000; 59:61-3.
116. Le Thi Huong D, Wechsler B, Papo T, et al. Arterial lesions in Behçet's disease. A study in 25 patients. J Rheumatol 1995;22:2103-13.
117. Tuzun H, Besirli K, Sayin A, et al. Management of aneurysms in Behcet's syndrome: an analysis of 24 patients. Surgery 1997;121:150-6.
118. Hosaka A, Miyata T, Shigematsu H, et al. Long-term outcome after surgical treatment of arterial lesions in Behcet disease. J Vasc Surg 2005;42:116-21.
119. Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behcet disease. Current opinion in rheumatology. 2005;17:1-8.
120. Goueffic Y, Pistorius MA, Heymann MF, et al. Association of aneurysmal and occlusive lesions in Behcet's disease. Ann Vasc Surg 2005;19:276-9.
121. Ko GY, Byun JY, Choi BG, Cho SH. The vascular manifestations of Behcet's disease: angiographic and CT findings. Br J Radiol 2000;73:1270-4.
122. Ozkurt H, Oztora F, Tunc S, Basak M. Pseudoaneurysm of the renal interlobar artery in Behcet's disease. Acta Radiol 2006;47:1000-2.
123. Bartlett ST, McCarthy WJ 03rd, Palmer AS, et al. Multiple aneurysms in Behcet's disease. Arch Surg 1988;123:1004-8.
124. Urayama A, Sakuragi S, Saki F, Tanaka Y, Koseki T. Angio Behçet's syndrome. In: Inaba GI, ed. Proceedings of the International Conference on Behçet's Disease, October 23-24, 1981: University of Tokyo Press 1982:171.
125. Wenger M, Baltaci M, Klein-Weigel P, et al. 18F-FDG-positron emission tomography for diagnosis of large vessel arteritis in Behcet's disease. Adv Exp Med Biol 2003;528:435-6.
126. Robenshtok E, Krause I. Arterial involvement in Behcet's disease--the search for new treatment strategies. Isr Med Assoc J. 2004;6:162-3.
127. Ceyran H, Akcali Y, Kahraman C. Surgical treatment of vasculo-Behcet's disease. A review of patients with concomitant multi- ple aneurysms and venous lesions. Vasa 2003;32:149-53.
128. Shepherd RF, Rooke T. Uncommon arteri- opathies: what the vascular surgeon needs to know. Semin Vasc Surg 2003;16:240-51.
129. Nitecki SS, Ofer A, Karram T, et al. Abdominal aortic aneurysm in Behcet's disease: new treatment options for an old and challenging problem. Isr Med Assoc J 2004;6:152-5.
130. Erkan F, Gul A, Tasali E. Pulmonary mani- festations of Behcet's disease. Thorax 2001;56:572-8.
131. Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in Behcet disease: a cumulative analysis. Chest 2005;127:2243-53.
132. Erkan F. Pulmonary involvement in Behçet disease. Curr Opin Pulm Med 1999;5:314-8.
133. Hamuryudan V, Er T, Seyahi E, et al. Pulmonary artery aneurysms in Behcet syndrome. Am J Med 2004;117:867-70.
134. Hamuryudan V, Yurdakul S, Moral F, et al. Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. Br J Rheumatol 1994;33:48-51.
135. Kohno S, Fujikawa M, Kanda T, et al. A case of Behcet's syndrome with rupture of a pulmonary aneurysm: autopsy findings and a literature review. Jpn J Med 1986;25:293-300.
136. Yazici H. Behcet's syndrome: where do we stand? Am J Med 2002;112:75-6.
137. Raz I, Okon E, Chajek-Shaul T. Pulmonary manifestations in Behçet's syndrome. Chest 1989;95:585-9.
138. Stricker H, Malinverni R. Multiple, large aneurysms of pulmonary arteries in Behçet's disease. Clinical remission and radiologic resolution after corticosteroid therapy. Arch Intern Med 1989;149:925-7.
139. Hughes JP, Stovin PGI. Segmental pulmonary artery aneurysms with peripheral venous thrombosis. Brit J Dis Chest 1959;53:19-27.
140. Erkan D, Yazici Y, Sanders A, et al. Is Hughes-Stovin syndrome Behcet's disease? Clin Exp Rheumatol 2004;22:S64-8.
141. Denecke T, Staeck O, Amthauer H, Hanninen EL. PET/CT visualises inflammatory activity of pulmonary artery aneurysms in Behcet disease. Eur J Nucl Med Mol Imaging 2007;34:970.
142. Sirmali M, Aloglu HV, Ozcakar L, Kaya S. Bilateral giant pulmonary artery aneurysms early in Behcet's disease. Eur J Cardiothorac Surg 2003;24:1033.
143. Efthimiou J, Johnston C, Spiro SG, Turner-Warwick M. Pulmonary disease in Behçet's syndrome. Q J Med 1986;58:259-80.
144. Hamuryudan V, Oz B, Tuzun H, Yazici H. The menacing pulmonary artery aneurysms of Behcet's syndrome. Clin Exp Rheumatol 2004;22:S1-3.
145. Baki K, Villiger PM, Jenni D, et al. Behcet's disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatment. Ann Rheum Dis 2006;65:1531-2.
146. Cantasdemir M, Kantarci F, Mihmanli I, et al. Emergency endovascular management of pulmonary artery aneurysms in Behcet's disease: report of two cases and a review of the literature. Cardiovasc Intervent Radiol 2002;25:533-7.
147. Saba D, Saricaoglu H, Bayram AS, et al. Arterial lesions in Behcet's disease. Vasa 2003;32:75-81.
148. Yazici H, Fresko I, Yurdakul S. Behcet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007;3:148-55.
149. Tunaci A, Berkmen YM, Gokmen E. Thoracic involvement in Behcet's disease: pathologic, clinical, and imaging features. AJR Am J Roentgenol 1995;164:51-6.
150. Lakhanpal S, Tani K, Lie JT, et al. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985;16:790-5.
151. Vaiopoulos G, Stamatelos G, Aessopos A, Michael S, Christopoulos G, Kaklamanis PH. Asymptomatic pericarditis in Ada- mantiadis-Behcet's disease. Clin Exp Rheumatol 1995;1:649-51.
152. Okcun B, Baran T, Babalik E, Kucukoglu S. Multichamber masses and constrictive pericarditis in Behcet's disease. Clin Exp Rheumatol 2003;21:S55.
153. Ben Dhaou B, Ketari S, Boussema F, et al. Pericarditis in Behçet's disease. 12th International Conference on Behçet's disease 2006; Lisbon: Clin Exp Rheumatol 2006. p. S-22, C8.
154. Wechsler B, Le Thi Huong D, Kieffer E. Manifestations cardio-vasculaires de la maladie de Behçet. Ann Med Interne (Paris) 1999;150:542-54.
155. Mirone L, Altomonte L, Ferlisi EM, Zoli A, Magaro M. Behcet's disease and cardiac arrhythmia. Clin Rheumatol 1997;16:99-100.
156. Higashihara M, Mori M, Takeuchi A, et al. Myocarditis in Behcet's disease--a case report and review of the literature. J Rheumatol 1982;9:630-3.
157. Yavuz B, Sahiner L, Akdogan A, et al. Left and right ventricular function is impaired in Behcet's disease. Echocardiography 2006;23:723-8.
158. Gurgun C, Ercan E, Ceyhan C, et al. Cardiovascular involvement in Behcet's disease. Jpn Heart J 2002;43:389-98.
159. Bozkurt A, Akpinar O, Uzun S, et al. Echocardiographic findings in patients with Behcet's disease. Am J Cardiol 2006;97:710-5.
160. Bletry O, Mohattane A, Wechsler B, et al. Atteinte cardiaque de la maladie de Behçet. Douze observations. Presse Med 1988;17:3288-91.
161. Schirmer M, Weidinger F, Sandhofer A, et al. Valvular disease and myocardial infarc- tions in a patient with Behcet disease. J Clin Rheumatol 2003;3:316-20.
162. McDonald GS, Gad-Al-Rab J. Behcet's disease with endocarditis and the Budd-Chiari syndrome. J Clin Pathol 1980;33: 660-9.
163. Shiran A, Zisman D, Karkabi B, et al. Behcet's aortitis mimicking aortic valve endocarditis with subaortic complications. J Am Soc Echocardiogr 2006;19:578 e1-4.
164. Okada K, Eishi K, Kitoh Y, et al. Huge aneurysm of the sinus of Valsalva following infective endocarditis in Behcet's disease. J Heart Valve Dis 1997;6:179-80.
165. Ozkan M, Emel O, Ozdemir M, Yurdakul S, Kocak H, Ozdogan H, et al. M-mode, 2-D and Doppler echocardiographic study in 65 patients with Behcet's syndrome. Eur Heart J 1992;13:638-41.
166. Vaya A, Forner MJ, Estelles A, et al. Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation. Haematologica 2000;85:425-8.
167. Tursen U, Ulubas B, Kaya TI, et al. Cardiac complications in Behcet's disease. Clin Exp Dermatol 2002;27:651-3.
168. Kaneko Y, Tanaka K, Yoshizawa A, et al. Successful treatment of recurrent intracardiac thrombus in Behcet's disease with immunosuppressive therapy. Clin Exp Rheumatol. 2005;23:885-7.
169. Toumi S, Ben Fredj F, Gnaya H, et al. Left intracardiac thrombosis: an exceptional complication revealing Behçet's disease. 12th International Conference of Behçet's disease; 2006; Lisbon: Clin Exp Rheumatol 2006. p. S-24, C0.
170. Mogulkoc N, Burgess MI, Bishop PW. Intracardiac thrombus in Behcet's disease: a systematic review. Chest 2000;118: 479-87.
171. Yoshida S, Fujimori K, Hareyama M, Nakata T. Cardiac thrombus in Behcet disease. Chest 2001;120:688-9.
172. Toscano Rico M, Rodrigues P, Machado J, et al. Angio-Behcet with severe cardiac involvement. Lupus 2003;12:70-1.
173. Noureddine M, Charei N, Drighil A, Chraibi N. Right intracardiac thrombus in Behcet's disease. Arch Mal Coeur Vaiss 2004;97:925-8.
174. Huong DL, Wechsler B, Papo T, et al. Endomyocardial fibrosis in Behcet's disease. Ann Rheum Dis 1997;56:205-8.
175. Atzeni F, Sarzi-Puttini P, Doria A, et al. Behcet's disease and cardiovascular involvement. Lupus 2005;14:723-6.
176. Siepmann M, Kirch W. Coronary anomaly in Behcet's syndrome. Rheumatol Int 1997;17:39-42.
177. Kosar F, Sahin I, Gullu H, Cehreli S. Acute myocardial infarction with normal coronary arteries in a young man with the Behcet's disease. Int J Cardiol 2005;99:355-7.
178. Tezcan H, Yavuz S, Fak AS, Aker U, Direskeneli H. Coronary stent implanta- tion in Behcet's disease. Clin Exp Rheumatol 2002;20:704-6.
179. Kusuyama T, Nakamura Y, Yamagishi H, et al. Unruptured aneurysm of the sinus of valsalva with Behcet's disease. Circ J 2002;66:107-8.
180. Zeigmond P, Bobinski L, Bostrom S. Behçet's disease, associated with sub- arachnoid haemorrhage due to intracranial aneurysm. Acta Neur Chir (Wien) 2005;147:569-71.
181. Ho CL, Deruytter MJ. Manifestations of Neuro-Behcet's disease. Report of two cases and review of the literature. Clin Neurol Neurosurg 2005;107:310-4.
182. Kizilkilic O, Kocer N. Manifestations of Neuro-Behcet's disease: Report of two cases and review of the literature. Clin Neurol Neurosurg 2006;108:616-7.
183. Kizilkilic O, Albayram S, Adaletli I, et al. Endovascular treatment of Behcet's disease-associated intracranial aneurysms: report of two cases and review of the literature. Neuroradiology 2003;45:328-34.
184. Nakasu S, Kaneko M, Matsuda M. Cerebral aneurysms associated with Behcet's disease: a case report. J Neurol Neurosurg Psychiatry 2001;70:682-4.
185. Rosenstingl S, Dupuy E, Alves O, et al. Behcet's disease manifested as a intracranial aneurysm. La Revue de Medecine Interne 2001;22:177-82.
186. Hatemi G, Silman A, Bang D, et al. EULAR recommendations for the management of Behcet's disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2008:ard. 2007. 080432.